CJC-1295/Ipamorelin Blend 10MG

CJC-1295 Ipamorelin blend Canada from Maple Research Labs combines two complementary growth hormone secretagogue peptides in a single 10mg research vial with verified 99%+ purity.

The CJC-1295 Ipamorelin blend combines two of the most extensively studied growth hormone secretagogue peptides into a single 10mg research vial. This blend contains 5mg of CJC-1295 (No DAC), also known as Mod GRF 1-29, and 5mg of Ipamorelin, a selective growth hormone releasing peptide. Researchers in Canada studying the synergistic mechanisms of GHRH analogs and GHRPs can access both compounds in a pre-blended, research-ready format from Maple Research Labs.

CJC-1295 Ipamorelin Blend Canada Research Overview

Researchers across Canada choose Maple Research Labs for verified purity and same-day shipping on all orders.

Research Background on CJC-1295 Ipamorelin Blend

CJC-1295 (No DAC) is a modified growth hormone releasing hormone analog consisting of 29 amino acids with substitutions at positions 2, 8, 15, and 27 to improve metabolic stability and receptor binding affinity. In preclinical research, CJC-1295 has demonstrated the ability to stimulate growth hormone secretion through the GHRH receptor pathway while maintaining the pulsatile release pattern that characterizes physiological growth hormone regulation. Research by Ionescu and Bhatt (2006) examined the pharmacokinetic properties of modified GRF analogs, establishing the foundation for ongoing research into this peptide class.

Ipamorelin is a pentapeptide growth hormone secretagogue that acts through the ghrelin receptor (GHS-R1a) to stimulate growth hormone release. Unlike other GHRPs, Ipamorelin has been shown in animal models to exhibit high selectivity for growth hormone release without significantly affecting cortisol, prolactin, or ACTH levels. Research by Raun et al. (1998) characterized Ipamorelin as a potent and selective growth hormone secretagogue in preclinical models, distinguishing it from earlier generation GHRPs with broader endocrine effects.

Synergistic Research Applications of This Blend

The combination of CJC-1295 and Ipamorelin in a single research blend allows investigators to study the synergistic interaction between GHRH-pathway and ghrelin-pathway stimulation of growth hormone release. These two mechanisms operate through distinct receptor systems and intracellular signaling cascades, and preclinical evidence suggests that concurrent activation may produce a greater growth hormone response than either compound alone. This CJC-1295 Ipamorelin blend provides a convenient format for researchers exploring dual-pathway activation without the need to reconstitute and combine separate compounds.

Product Specifications

• CAS Number: Blend (CJC-1295: 863288-34-0 / Ipamorelin: 170851-70-4)
• Molecular Formula: Blend
• Molecular Weight: CJC-1295: 3367.97 g/mol / Ipamorelin: 711.85 g/mol
• Purity: >99%+ (HPLC verified, each component)
• Form: Lyophilized powder
• Quantity: 10mg per vial (5mg CJC-1295 No DAC + 5mg Ipamorelin)

Reconstitution and Storage Guidelines

Reconstitute this CJC-1295 Ipamorelin blend with bacteriostatic water by injecting the solvent slowly along the vial wall. Do not shake the vial. Gently swirl until the lyophilized powder is fully dissolved. Once reconstituted, store the solution at 2 to 8 degrees Celsius and use within 30 days for optimal peptide stability. Prior to reconstitution, store the sealed vial at minus 20 degrees Celsius for long-term preservation or at 2 to 8 degrees Celsius for short-term storage of up to 90 days. Protect from light and repeated freeze-thaw cycles.

Quality Assurance at Maple Research Labs

Every batch of CJC-1295 Ipamorelin blend from Maple Research Labs undergoes rigorous HPLC purity testing to verify that each component meets our 99%+ purity standard. We provide third-party COA testing documentation so researchers can independently verify the identity and purity of the compounds they are working with. This commitment to analytical transparency is the foundation of our reputation among Canadian peptide researchers and distinguishes Maple Research Labs from suppliers who do not provide independent verification of their products.

Researchers ordering CJC-1295 Ipamorelin blend Canada receive a dual-peptide formulation with verified purity. Each CJC-1295 Ipamorelin blend Canada vial is tested by independent laboratories. Maple Research Labs ships all CJC-1295 Ipamorelin blend Canada orders same-day from our Canadian facility.

Related Research Peptides from Maple Research

Researchers studying growth hormone secretagogue pathways may also be interested in the individual components available separately: CJC-1295 (No DAC) and Ipamorelin 5MG. For researchers exploring the DAC-modified variant, we also offer CJC-1295 DAC. All peptides ship same-day from Canada with third-party purity verification and discreet packaging.

For research purposes only. Not for human consumption. Not for diagnostic or therapeutic use.